publication date: Jan. 22, 2021

Curran departs as chair of NRG Oncology

“It would be nice at least once in my life to have just one job”

By Paul Goldberg

Walter J. (Wally) Curran, Jr., has stepped down from his positions as NRG Oncology presiding group chair and as one of the three principal investigators of the NRG Oncology.

Late last year, Curran said he would leave his positions at Emory University, where he served as executive director and chair of the Department of Radiation Oncology at Winship Cancer Institute, to become the global chief medical officer of GenesisCare, an international provider of cancer and cardiology care (The Cancer Letter, Oct. 23, 2020).

Originally, Curran intended to remain in his NRG Oncology job.

However, his plans have changed.

“He expressed to us concern that the responsibilities of his new role will not provide him with the ability to continue his outstanding work as one of NRG Oncology’s group chairs,” his co-chairs Norman Wolmark and Robert Mannel said in a letter to NRG Oncology members.

Curran has served as the group chairman of the RTOG, one of NRG Oncology’s three legacy groups, dating back to 1997.

“I made a decision that it would be nice at least once in my life to have just one job,” Curran, whose first day at GenesisCare was Jan. 20, said to The Cancer Letter. “It has been a wonderful chapter in my life to serve as group chair of RTOG and group chair of NRG Oncology, and I am proud of having conducted the practice-defining trials and practice-changing trials, and training a generation of young researchers, but ultimately … Continue reading Curran departs as chair of NRG Oncology

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2021 The Cancer Letter Inc.